Mereo Biopharma Group Plc's market cap is currently $444.09M. The company's EPS TTM is $; its P/E ratio is ―; Mereo Biopharma Group Plc is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 10.00M	$ 1.51M	$ 36.46M	$ 393.00K	$ -122.00K
Gross Profit	$ 7.43M	$ 571.00K	$ 18.56M	$ -15.95M	$ -23.73M
Operating Income	$ -28.42M	$ -43.57M	$ -20.94M	$ -37.57M	$ -39.52M
EBITDA	$ -26.06M	$ -42.06M	$ -5.00M	$ -37.52M	$ -37.56M
Net Income	$ -29.47M	$ -34.20M	$ 12.72M	$ -163.63M	$ -34.84M
Balance Sheet
Cash & Short-Term Investments	$ 57.42M	$ 56.33M	$ 94.30M	$ 23.47M	$ 16.35M
Total Assets	$ 66.50M	$ 88.08M	$ 126.42M	$ 62.95M	$ 86.45M
Total Debt	$ 5.95M	$ 12.77M	$ 16.76M	$ 17.94M	$ 32.42M
Net Debt	$ -51.47M	$ -43.56M	$ -77.54M	$ -5.53M	$ 16.07M
Total Liabilities	$ 15.96M	$ 26.21M	$ 38.41M	$ 77.92M	$ 46.19M
Stockholders' Equity	$ 50.54M	$ 61.87M	$ 88.00M	$ -14.97M	$ 40.26M
Cash Flow
Free Cash Flow	$ -21.55M	$ -38.83M	$ -5.77M	$ -28.36M	$ -45.95M
Operating Cash Flow	$ -21.13M	$ -38.82M	$ -5.24M	$ -28.34M	$ -45.93M
Investing Cash Flow	$ -419.00K	$ 1.50M	$ -421.00K	$ 1.50M	$ 43.30M
Financing Cash Flow	$ 7.97M	$ -784.00K	$ 77.65M	$ 34.74M	$ -5.71M

Currency in USD

Mereo Biopharma Group Plc Earnings and Revenue History

Income Statement >

Mereo Biopharma Group Plc Debt to Assets

Balance Sheet >

Mereo Biopharma Group Plc Cash Flow

Cash Flow >

Mereo Biopharma Group Plc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing